Literature DB >> 25015727

Definition of Barrett's esophagus dysplasia: are we speaking the same language?

Massimo Rugge, Marco Pizzi, Carlo Castoro.   

Abstract

The definition of Barrett's esophagus (BE) is still a matter of debate. The diagnostic criteria adopted around the world for both BE and BE-related pre-cancerous lesions are inconsistent, particularly between Eastern and Western pathologists. From a clinical perspective, these different clinico-biological approaches may affect how the literature is interpreted, with detrimental effects on the clinical management of patients. The present review focuses on the major discrepancies in the field, covering both the non-neoplastic and the pre-cancerous lesions associated with Barrett's disease.

Entities:  

Mesh:

Year:  2015        PMID: 25015727     DOI: 10.1007/s00268-014-2692-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  35 in total

1.  Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy.

Authors:  Matteo Fassan; Marco Pizzi; Fabio Farinati; Donato Nitti; Vittorina Zagonel; Robert M Genta; Massimo Rugge
Journal:  Am J Clin Pathol       Date:  2012-05       Impact factor: 2.493

2.  Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels?

Authors:  Yuji Amano; Norihisa Ishimura; Kenji Furuta; Yoshiko Takahashi; Daisuke Chinuki; Yoshiyuki Mishima; Ichiro Moriyama; Hiroyuki Fukuhara; Shunji Ishihara; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  Gastrointest Endosc       Date:  2006-08       Impact factor: 9.427

3.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

Review 4.  Gastric dysplasia: the Padova international classification.

Authors:  M Rugge; P Correa; M F Dixon; T Hattori; G Leandro; K Lewin; R H Riddell; P Sipponen; H Watanabe
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

5.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

7.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

Review 8.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

9.  Gastrointestinal epithelial neoplasia: Vienna revisited.

Authors:  M F Dixon
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

View more
  4 in total

1.  Dysplastic Barrett's esophagus.

Authors:  Giovanni Zaninotto; John G Hunter
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

2.  Big data as the universal language for Barrett's esophagus.

Authors:  Robert M Genta
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

Review 3.  BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Authors:  Cathy Bennett; Paul Moayyedi; Douglas A Corley; John DeCaestecker; Yngve Falck-Ytter; Gary Falk; Nimish Vakil; Scott Sanders; Michael Vieth; John Inadomi; David Aldulaimi; Khek-Yu Ho; Robert Odze; Stephen J Meltzer; Eamonn Quigley; Stuart Gittens; Peter Watson; Giovanni Zaninotto; Prasad G Iyer; Leo Alexandre; Yeng Ang; James Callaghan; Rebecca Harrison; Rajvinder Singh; Pradeep Bhandari; Raf Bisschops; Bita Geramizadeh; Philip Kaye; Sheila Krishnadath; M Brian Fennerty; Hendrik Manner; Katie S Nason; Oliver Pech; Vani Konda; Krish Ragunath; Imdadur Rahman; Yvonne Romero; Richard Sampliner; Peter D Siersema; Jan Tack; Tony C K Tham; Nigel Trudgill; David S Weinberg; Jean Wang; Kenneth Wang; Jennie Y Y Wong; Stephen Attwood; Peter Malfertheiner; David MacDonald; Hugh Barr; Mark K Ferguson; Janusz Jankowski
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

4.  Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study.

Authors:  Luigi Dall'Olmo; Matteo Fassan; Elisa Dassie; Marco Scarpa; Stefano Realdon; Francesco Cavallin; Matteo Cagol; Giorgio Battaglia; Marco Pizzi; Vincenza Guzzardo; Erica Franceschinis; Gianfranco Pasut; Massimo Rugge; Giovanni Zaninotto; Nicola Realdon; Carlo Castoro
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.